Mainstay Medical Holdings plc announced that Jason Hannon, Chief Executive Officer, and Matthew Onaitis, Chief Financial Officer, will present a corporate overview at the LifeSci Partners Private Healthcare Company Virtual Summer Symposium on Wednesday, 5 August, 2020.
DUBLIN--(BUSINESS WIRE)-- Mainstay Medical Holdings plc (“Mainstay” or the “Company”) today announced that Jason Hannon, Chief Executive Officer, and Matthew Onaitis, Chief Financial Officer, will present a corporate overview at the LifeSci Partners Private Healthcare Company Virtual Summer Symposium on Wednesday, 5 August, 2020.
|
Presentation Details: |
||||||||
|
Date: |
5 August, 2020 |
|||||||
|
Time: |
2:30 PM ET |
|||||||
To register, please click here.
About Mainstay Medical Holdings
Mainstay Medical Holdings is a medical device company focused on commercializing an innovative implantable restorative neurostimulation system, ReActiv8®, for people with disabling Chronic Low Back Pain (CLBP). The Company is headquartered in Dublin, Ireland and has subsidiaries operating in Ireland, the United States, Australia, Germany and the Netherlands.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200728005151/en/
PR and IR Enquiries:
LifeSci Advisors, LLC (IR for U.S.)
Brian Ritchie
Tel: + 1 (212) 915-2578
Email: britchie@lifesciadvisors.com
The Ruth Group (PR for U.S.)
Annika Haberland
Tel: +1 (720) 412-9042
Email: ahaberland@theruthgroup.com
FTI Consulting (for Ireland/Europe)
Jonathan Neilan or Patrick Berkery
Tel. : +353 1 765 0886
Email: mainstay@fticonsulting.com
Source: Mainstay Medical Holdings plc
View this news release online at:
http://www.businesswire.com/news/home/20200728005151/en
